Le Lézard
Classified in: Health
Subject: MRR

Tissue Diagnostics Market worth $7.3 billion by 2027 - Exclusive Report by MarketsandMarketstm

CHICAGO, July 1, 2022 /PRNewswire/ -- According to the new market research report "Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special Staining), Disease(Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) - Global Forecast to 2027", published by MarketsandMarketstm, the Tissue Diagnostics Market is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, at a CAGR of 6.6% during the forecast period.

MarketsandMarkets Logo

Browse in-depth TOC on "Tissue Diagnostics Market"
172 ? Tables
57 ? Figures
246 ? Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949

The growth of this market is majorly driven by growing cancer cases, rising geriatric population with subsequent growth in chronic and infectious diseases. However, Lack of infrastructure and low awareness in middle and low income countries are some of the challenges for which may hinder the growth of this market.

Antibodies in the consumable' segment to witness the highest shares during the forecast period."

Based on the product, the tissue diagnostics market is classified into tissue diagnostics consumables (Antibodies, Kits, Reagents, Probes) and tissue diagnostics Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments). The antibodies in the consumables segment is expected to dominate the market. These are primarily used in the research and diagnosis of cancers, infectious diseases, and autoimmune & hormonal disorders hence rising usage of antibodies in the research as well diagnosis is driving the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949

US dominates the North American tissue diagnostics market

Based on the North American region, the tissue diagnostic market is divided into US and Canada. US is expected to dominate the market. The high healthcare budget, the increasing incidence of cancer and funding for cancer research, and the rising availability of technologically advanced products, is the key factor driving market growth in the US.

The major players operated in US of the tissue diagnostics market are Danaher Corporation (US), Thermo Fisher Scientific, Inc (US), Abbott (US), Agilent Technologies Inc. (US), Becton, Dickinson and Company (BD) (US), Bio SB (US), Biogenix (US), Cell Signaling Technology, Inc (US), and Hologic Inc. (US)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1063949

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) - Global Forecast to 2027

Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) (2022 - 2026)

About MarketsandMarketstm 

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model ? GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/tissue-diagnostics-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/tissue-diagnostics.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

These press releases may also interest you

at 12:39
Otsuka Canada Pharmaceutical Inc. (OCPI) today announced that Health Canada has approved KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing...

at 12:34
The Multiple Sclerosis Association of America (MSAA) is proud to announce the launch of the Ultimate MS Treatment Guide ? a unique and comprehensive tool to help people with multiple sclerosis learn about the different FDA-approved disease-modifying...

at 12:30
Cadillac Fairview (CF) today announced its achievement of WELL Core Certification at Gold level for its iconic Toronto-Dominion Centre (TD Centre) complex consisting of six office towers totaling 4.3 million square feet. The company reinforced its...

at 12:20
We are pleased to share the exciting news that Jennifer Cudlipp, Chief Operating Officer, LifeLabs, has been recognized by Business in Vancouver in BC500 list for the second consecutive year. Celebrating ?visionaries, innovators and trailblazers',...

at 12:15
Today, Inc. revealed that Mytonomy, Inc. is No. 396 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the...

at 12:12
Bioidentical hormone replacement therapy (BHRT) helps restore your natural hormone levels to what they were when you were younger. Anyone who experiences symptoms that might be related to hormone imbalance is a candidate for BHRT, including...

News published on 1 july 2022 at 11:30 and distributed by: